admin Posted on 7:40 pm

Industry to FDA: No evidence of liver disease or elevated liver function in CBD study participants

Early results of an industry-sponsored, human-safety study on hemp-derived CBD consumption show no evidence of liver toxicity or disease in its 839 participants.
Industry to FDA: No evidence of liver disease or elevated liver function in CBD study participants is a post from: Hemp Industry Daily: Financial, Legal & business news for hemp & CBD entrepreneurs

Leave a Reply

Your email address will not be published. Required fields are marked *